Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics

MLA

Peng Zou, et al. “Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics.” Journal of Pharmacy & Pharmaceutical Sciences, vol. 15, no. 2, Apr. 2012. EBSCOhost, https://doi.org/10.18433/J34S4N.

APA

Peng Zou, Nan Zheng, Yanke Yu, Shanghai Yu, Wei Sun, Donna McEachem, Yongsheng Yang, Lawrence X Yu, Shaomeg Wang, & Duxin Sun. (2012). Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics. Journal of Pharmacy & Pharmaceutical Sciences, 15(2). https://doi.org/10.18433/J34S4N

Chicago

Peng Zou, Nan Zheng, Yanke Yu, Shanghai Yu, Wei Sun, Donna McEachem, Yongsheng Yang, Lawrence X Yu, Shaomeg Wang, and Duxin Sun. 2012. “Preclinical Pharmacokinetics of MI-219, a Novel Human Double Minute 2 (HDM2) Inhibitor and Prediction of Human Pharmacokinetics.” Journal of Pharmacy & Pharmaceutical Sciences 15 (2). doi:10.18433/J34S4N.